L. Dupont (Leuven, Belgium), A. Boehler (Zurich, Switzerland)
Serum KL-6 as a marker for bronchiolitis obliterans syndrome after lung transplantation S. Ohshimo, U. Sommerwerck, M. Kamler, F. Bonella, A. Cui, H. G. Jakob, N. Kohno, J. Guzman, H. Teschler, U. Costabel (Essen, Bochum, Germany; Kasumi, Minami-ku, Hiroshima, Japan)
| |
Do nitrites (NO2) and nitrates (NO3) have a role in the development of bronchiolitis obliterans syndrome (BOS) in lung transplant recipients? J. Musil, R. Davidová, L. Valentová-Bartáková, R. Lischke, P. Pafko, J. Chládek (Prague, Hradec Králové, Czech Republic)
| |
Does smoking affect the prevalence of BOS after lung transplantation? G. Verleden, B. Vanaudenaerde, R. Vos, S. De Vleeschauwer, D. Van Raemdonck, L. Dupont (Leuven, Belgium)
| |
Epidemiology of community acquired viral respiratory infections in a cohort of lung transplant recipients (LTR) F. Meloni, D. Lilleri, V. Conio, V. Rognoni, T. Oggionni, G. Gerna, F. Bini (Pavia, Italy)
| |
Unexpected malignancies in explanted lungs – incidence and outcome- a single centre experience M. A. Hoda, P. Jaksch, S. Taghavi, G. Lang, W. Klepetko (Vienna, Austria)
| |
Introduction of a new preservation solution in an experimental lung transplantation model N. Pizanis, A. Petrov, J. Heckmann, U. Rauen, P. Yablonsky, H. Jakob, M. Kamler (Essen, Germany; St.Petersburg, Russian Federation)
| |
Characterization of primary graft dysfunction after lung transplantation using 64-MSCT imaging E. Belmaati, C. Jensen, I. Steffensen, M. Iversen, K. F. Kofoed, M. B. Nielsen (Copenhagen, Denmark)
| |
Experience with lung transplantation in lymphangioleiomyomatosis (LAM) in our center G. Mora, P. Ussetti, C. Garcia, L. G. G. Cristina, L. Rosalia, A. De Pablo, M. C. Carreno, F. Maria Jose, V. Andres (Madrid, Spain)
| |
Dramatic improvement of survival after lung transplantation since 2002 in Grenoble C. Saint Raymond, V. Costache, O. Chavanon, D. Blin, C. Pison (Grenoble, France)
| |
Lung retransplantation in cystic fibrosis (CF). Is it justifiable? C. Garcia-Fadul, C. Lopez, G. Mora, R. Laporta, A. De Pablo, A. Trisan, A. Valera, P. Ussetti, M. J. Ferreiro (Madrid, Spain)
| |
Long-term follow-up of lung transplant recipients with obstructive airway complications J. Gottlieb, M. Dierich, T. Fühner, O. Wiesner, A. Simon, T. Welte (Hannover, Germany)
| |
Lung transplantation for lymphangioleiomyomatosis: the European experience C. Benden, F. Rea, J. Behr, P. Corris, M. Stern, R. Speich, A. Boehler (Zurich, Switzerland; Padua, Italy; Munich, Germany; Newcastle, United Kingdom; Suresnes, France)
| |
Bone mineral density in patients with chronic respiratory failure listed for transplantation E. Kochetkova, M. A. Weiller, A. C. Metivier, S. Hirschi, N. Santelmo, R. Kessler, G. Massard (Strasbourg, France)
| |
Targeted delivery of catalase to the pulmonary endothelium preserves graft function of non-heart-beating donor lungs in pigs G. Preissler, F. Loehe, I. Huff, H. Ebersberger, V. Shuvaev, I. Hermanns, R. Buhl, C. Taube, S. Albelda, V. Muzykantov, R. Wiewrodt (Munich, Mainz, Germany; Philadelphia, United States Of America)
| |
Do NHBD and HBD recipients have different airway inflammatory profiles early after LTx? S. De Vleeschauwer, R. Vos, V. Bart, D. Van Raemdonck, L. Dupont, G. Verleden (Leuven, Belgium)
| |
Longitudinal assessment of CD4+CD25highCD69- treg cells in a cohort of lung transplant recipients (LTR). An association with chronic graft rejection F. Meloni, C. Tinelli, N. Solari, M. Morosini, P. Draghi, M. Viganò, A. De Silvestri, A. M. Fietta (Pavia, Italy)
| |
Knowlege and approaches about organ donation and lung transplantation M. Aydin, B. Ozcelik, G. Okumus, D. Tas, Z. Kartaloglu, K. Ecerkale, E. Kiyan, O. Arseven (Istanbul, Turkey)
| |